US BANCORP \DE\ - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 111 filers reported holding FIBROGEN INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$499
-71.7%
578
-11.6%
0.00%
Q2 2023$1,766
-86.9%
654
-9.2%
0.00%
Q1 2023$13,435
+16.5%
7200.0%0.00%
Q4 2022$11,534
-17.6%
720
-34.9%
0.00%
Q3 2022$14,000
+16.7%
1,106
-2.3%
0.00%
Q2 2022$12,000
-25.0%
1,132
-14.2%
0.00%
Q1 2022$16,000
-60.0%
1,320
-52.5%
0.00%
Q4 2021$40,000
+29.0%
2,780
-7.6%
0.00%
Q3 2021$31,000
-63.1%
3,008
-4.4%
0.00%
Q2 2021$84,000
-82.2%
3,145
-76.8%
0.00%
-100.0%
Q1 2021$472,000
+6.5%
13,583
+13.7%
0.00%0.0%
Q4 2020$443,000
-21.2%
11,950
-12.6%
0.00%0.0%
Q3 2020$562,000
+174.1%
13,670
+171.0%
0.00%0.0%
Q2 2020$205,000
+29.7%
5,044
+10.7%
0.00%
Q1 2020$158,000
+15700.0%
4,556
+32442.9%
0.00%
Q4 2019$1,000
-98.8%
14
-99.4%
0.00%
Q3 2019$81,000
-17.3%
2,186
+0.6%
0.00%
Q2 2019$98,000
+50.8%
2,172
+79.7%
0.00%
Q1 2019$65,000
+441.7%
1,209
+374.1%
0.00%
Q4 2018$12,000
-58.6%
255
-45.6%
0.00%
Q3 2018$29,000
+3.6%
469
+2.9%
0.00%
Q2 2018$28,000
-17.6%
456
-37.4%
0.00%
Q1 2018$34,000
+13.3%
728
+17.4%
0.00%
Q4 2017$30,000
+30.4%
620
+45.5%
0.00%
Q3 2017$23,000
+666.7%
426
+483.6%
0.00%
Q2 2017$3,000
+200.0%
73
+217.4%
0.00%
Q1 2017$1,000230.0%0.00%
Q4 2016$0230.00%
Other shareholders
FIBROGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 605,713$9,703,5225.73%
ARMISTICE CAPITAL, LLC 3,864,000$61,901,2801.08%
Logos Global Management LP 525,000$8,410,5000.98%
5AM Venture Management, LLC 225,583$3,613,8400.97%
Intercontinental Wealth Advisors, LLC 191,300$3,064,6260.91%
BHK Investment Advisors, LLC 87,550$1,402,5510.79%
Integral Health Asset Management, LLC 175,000$2,803,5000.59%
Nan Fung Group Holdings Ltd 34,106$546,3780.38%
Soleus Capital Management, L.P. 113,463$1,817,6770.26%
Point72 Asset Management, L.P. 4,781,645$76,601,9530.26%
View complete list of FIBROGEN INC shareholders